- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Nasdaq
Wall Street JournalEN
S
GPCR
Structure Therapeutics Inc ADR
66.55
-0.92-1.36%After Hours: 67.00 +0.45 +0.68%17:27 02/20 EST
OPEN/PREV CLOSE67.11/67.47
TODAY RANGE65.58-68.14
VOL940.51K
MARKET CAP4.60B
52 WEEK RANGE13.22-94.90
AVG VOL (3M)1.54M
% TURNOVER1.36%
TURNOVER--
P/E (TTM)-18.2419
% RANGE3.79%
EPS(TTM)-3.6482
P/E(FORWARD)-49.2963
P/B5.12
BVPS13.41
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP4.41B
SHARES OUTSTANDING69.14M
NEXT EARNINGS02/25-03/02
FREE FLOAT66.26M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·2d ago
Structure Therapeutics: The Dark Horse Has Taken The Lead - But Is It Enough?
Reuters·02/03 17:48
BUZZ-US-listed Novo shares slip after company flags sharp 2026 sales drop
Seeking Alpha·01/31 20:15
Key deals this week: Apple, McEwen Mining, IonQ, Leidos, and more
Seeking Alpha·01/30 17:55
Structure Therapeutics gains on report suggesting it may be a top takeover target
TipRanks·01/30 17:01
Midday Fly By: Warsh nominated for Fed chair, Apple reports Q1 beat
TipRanks·01/30 15:51
Structure Therapeutics emerges as top M&A target for big pharma, Axios says
Benzinga·01/30 15:44
'Structure Therapeutics could be pharma's next buyout candidate'- Axios
Benzinga·01/23 14:18
Weight Loss Drugs Market Is Crowded But Structure Therapeutics CEO Has A Strategy For It
Dow Jones·01/22 16:51
Structure Therapeutics Is Maintained at Overweight by JP Morgan
Dow Jones·01/22 16:51
Structure Therapeutics Price Target Raised to $105.00/Share From $65.00 by JP Morgan
Same Industry
Name/Symbol
Change%
Price